Live Status Check

NCT06223880 Recruiting Status

Real-time enrollment status for this major depressive disorder clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 7:17 AM UTC

NCT06223880 Status Summary

NCT NumberNCT06223880
Recruiting StatusRecruiting
ConditionMajor Depressive Disorder
PhaseClinical Trial
Target Enrollment350 participants
Active Locations40 sites in the US
SponsorAxsome Therapeutics, Inc.
Last Updated on CT.govJanuary 23, 2025 (Jan 23, 2025)

About NCT06223880 Enrollment Status

As of March 2, 2026: Clinical trial NCT06223880 is currently recruiting participants. This clinical trial study for major depressive disorder is actively seeking new participants at 40 locations across the United States. The study is sponsored by Axsome Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06223880

Is NCT06223880 still recruiting?

Yes, NCT06223880 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06223880 recruiting?

This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06223880?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06223880 status last updated?

The official ClinicalTrials.gov record for NCT06223880 was last updated Jan 23, 2025 (January 23, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial